Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,151 INR | -0.25% | +0.49% | +8.46% |
May. 30 | Advent International Receives 6-7 Bids for Bharat Serums | CI |
May. 16 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 |
Sales 2024 | 103B 1.24B | Sales 2025 * | 116B 1.39B | Capitalization | 864B 10.35B |
---|---|---|---|---|---|
Net income 2024 | 19.13B 229M | Net income 2025 * | 22.19B 266M | EV / Sales 2024 | 8.92 x |
Net cash position 2024 * | 25.25B 303M | Net cash position 2025 * | 40.68B 487M | EV / Sales 2025 * | 7.07 x |
P/E ratio 2024 |
48.3
x | P/E ratio 2025 * |
38.9
x | Employees | 18,468 |
Yield 2024 * |
0.29% | Yield 2025 * |
0.4% | Free-Float | 19.92% |
Latest transcript on Mankind Pharma Limited
1 day | +0.34% | ||
1 week | +1.12% | ||
Current month | +1.12% | ||
1 month | -2.42% | ||
3 months | +0.44% | ||
6 months | +8.61% | ||
Current year | +9.14% |
Managers | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 07-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 16-06-16 |
Pradeep Chugh
CMP | Compliance Officer | - | 16-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 22-07-31 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 22-07-31 |
Surendra Lunia
BRD | Director/Board Member | 61 | 15-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2,151 | -0.25% | 212 273 |
24-06-06 | 2,156 | +0.02% | 240,944 |
24-06-05 | 2,156 | +2.85% | 410,647 |
24-06-04 | 2,096 | -1.38% | 585,126 |
24-06-03 | 2,126 | -0.67% | 393,790 |
Delayed Quote NSE India S.E., June 07, 2024 at 02:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.14% | 10.35B | |
+43.64% | 754B | |
+39.42% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.92% | 217B | |
-2.62% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- MANKIND Stock